We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • INDUSTRY PRESS ROOM
  • SUBMISSIONS
  • MEDIA FILE
  • Create Account
  • Sign In
  • Sign Out
  • My Account
Free Newsletters
  • MAGAZINE
    • Current Issue
    • Archives
    • Digital Edition
    • Subscribe
    • Newsletters
  • STRATEGY
  • GLOBAL
  • LOGISTICS
  • MANUFACTURING
  • PROCUREMENT
  • VIDEO
    • News & Exclusives
    • Viewer Contributed
    • CSCMP EDGE 2022 Startup Alley
    • Upload your video
  • PODCAST ETC
    • Podcast
    • White Papers
    • Webcasts
    • Events
    • Blogs
      • Reflections
      • SCQ Forum
    • Mobile Apps
  • MAGAZINE
    • Current Issue
    • Archives
    • Digital Edition
    • Subscribe
    • Newsletters
  • STRATEGY
  • GLOBAL
  • LOGISTICS
  • MANUFACTURING
  • PROCUREMENT
  • VIDEO
    • News & Exclusives
    • Viewer Contributed
    • CSCMP EDGE 2022 Startup Alley
    • Upload your video
  • PODCAST ETC
    • Podcast
    • White Papers
    • Webcasts
    • Events
    • Blogs
      • Reflections
      • SCQ Forum
    • Mobile Apps
Home » Logistics of the COVID-19 vaccine: a lot left to work out
PERSPECTIVE

Logistics of the COVID-19 vaccine: a lot left to work out

Most of us will not have access to a vaccine until at least the middle of next year. That’s partly because our current medical supply chains aren’t equipped for a rollout of this scale and complexity.

October 19, 2020
David Maloney
No Comments

We’ve heard a lot about the race to develop a safe and effective COVID-19 vaccine, which hopefully will be ready for approval around the end of this year. However, just because there is a vaccine doesn’t mean it will be widely distributed right away. Most of us will not have access to a vaccine until at least the middle of next year.

There are many reasons why it will take much longer than we all hope, including the fact that much of the distribution planning can’t even begin until we know which vaccine candidates will be approved. A further complication is that the various vaccines have different handling requirements.

The CDC (Centers for Disease Control and Prevention) will coordinate U.S. distribution. The plan is to allocate vaccines to all 50 states, with the state health departments responsible for overseeing distribution from there. So far, states have responded quite differently to the pandemic. We can expect their distribution approaches to be widely disparate as well.

While the manufacture of leading candidates is beginning even before government approval, distribution will not ramp up as quickly. Most will be handled by current medical supply chains, which will expand some, but what is required is still light-years beyond their capacities. It’s unlikely that supply chain infrastructure not already associated with established and trusted medical channels will be incorporated into the distribution of the vaccine. Few distributors will invest in infrastructure they won’t use once the pandemic subsides.

A key factor is that at least two of the leading candidates require that vaccines remain at -70º C (-94º F) at all times. Even our current medical distribution models aren’t equipped for this. For instance, most of the doctors’ offices, pharmacies, and clinics that routinely distribute flu vaccines cannot maintain vaccines at these temperatures.

Such stringent requirements will limit the scale of distribution. And scale is a huge problem. There are 330 million Americans and 7.6 billion people in the world, all needing a vaccine. Most of the vaccines will require two doses. We don’t even know yet how long a vaccine is effective. Will we all require a yearly vaccine as with the flu shot? These are many of the unknowns that affect supply chains.

Actual distribution will follow allocation guidelines developed by the National Academies of Sciences, Engineering, and Medicine. There will be four phases, with initial doses going to health care workers, first responders, and those with serious health issues or living in nursing facilities. The second phase targets teachers, those in prisons and homeless shelters, essential workers, and people with other underlying conditions. Most Americans will not receive a dose until Phase 3 or 4.

It’s a simple matter of demand exceeding supply and capabilities. Don’t expect much change in our lives for quite some time yet.

  • Related Articles

    Out of sync and in the spotlight

    It’s time to prepare for health care’s biggest logistics challenge ever

    The times that try our supply chains

David maloney headshot
David Maloney is group editorial director of CSCMP's Supply Chain Quarterly.

Recent Articles by David Maloney

Is your data factual?

’Tis the season to be patient

Managing supply chains in a time of runaway inflation: interview with Paul Lord

You must login or register in order to post a comment.

Report Abusive Comment

Most Popular Articles

  • Survey: parcel delivery drivers are frustrated by using their own smartphones for work

  • Survey: most Americans unaware that truckers face shortage of parking spaces

  • Best practices in logistics sustainability

  • Supply chain executives not yet seeing expected results from technology investments

  • Postal Service plans to seize items mailed with fake stamps

Featured Video

20221107korber large vs

Enhancing Customer Experience with Your Supply Chain Strategy

Viewer Contributed
With the rise of e-commerce, many businesses have had to transform their warehouses to handle online orders in addition to regularly scheduled inventory shipments. This means warehouses need more information than ever before to ensure they can meet customers' needs. As a result, companies need to select warehouse...

FEATURED WHITE PAPERS

  • Five tips for parcel success in 2023

  • Guide to Pallet Rack Safety

  • 3PLs: Complete Orders Faster with Flexible Automation

  • A shipper's guide to navigating post-pandemic holiday freight

View More

Subscribe to Supply Chain Quarterly

Get Your Subscription
  • SUBSCRIBE
  • E-NEWSLETTERS
  • ADVERTISING
  • CUSTOMER CARE
  • CONTACT
  • ABOUT
  • STAFF
  • PRIVACY POLICY

Copyright ©2023. All Rights ReservedDesign, CMS, Hosting & Web Development :: ePublishing